SCHEMBL4673397

SCHEMBL4673397

O=C(O)C(O)=CC(=O)c1ccc(Cc2ccccc2)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
KMT2A Q03164 6/20 0.39
HPGD P15428 5/20 0.39
ALDH1A1 P00352 5/20 0.38
TBXAS1 P24557 4/20 0.38
MEN1 O00255 4/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
ABL1 P00519 1/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673394 1.00 ALOX5 (0.40) ALOX5KMT2AHPGDALDH1A1TBXAS1
SCHEMBL4673330 0.87 TBXAS1 (0.38) KMT2AHPGDALDH1A1TBXAS1MEN1
SCHEMBL4673762 0.87 ITGB1 (0.35) ALOX5KMT2AHPGDALDH1A1TBXAS1
SCHEMBL4678283 0.87 ALOX5 (0.40) ALOX5KMT2AHPGDALDH1A1MEN1
SCHEMBL4673757 0.87 ITGB1 (0.35) ALOX5KMT2AHPGDALDH1A1TBXAS1
SCHEMBL4673335 0.87 TBXAS1 (0.38) KMT2AHPGDALDH1A1TBXAS1MEN1
SCHEMBL4678282 0.87 ALOX5 (0.40) ALOX5KMT2AHPGDALDH1A1MEN1
SCHEMBL4676027 0.87 MAPT (0.39) ALOX5KMT2AHPGDALDH1A1TBXAS1
SCHEMBL4676029 0.87 MAPT (0.39) ALOX5KMT2AHPGDALDH1A1TBXAS1
SCHEMBL4670644 0.85 HCAR2 (0.39) MAPTLMNANPC1NFKB1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
CN-1335834-A Aromatic heterocyclic compounds having HIV integrase inhibitory activity SHIONOGI & CO (JP) 2002-02-13 CN disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 ALOX5 4375/4885KMT2A 597/4885HPGD 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.